Michael F Olson Selected Research

Michael F Olson Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 12/2004
7	Myotonic Dystrophy (Dystrophia Myotonica) 01/2023 - 01/2011
6	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2007
4	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2014
3	Hyperplasia 02/2024 - 06/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2016
3	Adenocarcinoma 01/2018 - 11/2016
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 08/2004
2	Papilloma (Papillomatosis) 10/2020 - 02/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024
1	Temporal Lobe Epilepsy 01/2022
1	Disease Progression 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014
1	Starvation 01/2013
1	Carcinogenesis 10/2012
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Inflammation (Inflammations) 09/2012
1	Adenoma (Adenomas) 09/2012
1	Warts (Wart) 12/2009
1	Intracranial Vasospasm 04/2008
1	Blister (Bulla) 07/2003

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2003
12	Phosphotransferases (Kinase)IBA 01/2023 - 12/2004
7	ActomyosinIBA 02/2024 - 01/2011
7	Lim KinasesIBA 11/2015 - 06/2007
5	Myosins (Myosin)IBA 11/2020 - 03/2014
5	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 02/2012 - 12/2004
3	CateninsIBA 02/2024 - 06/2011
3	Y 27632IBA 01/2018 - 10/2012
3	CollagenIBA 01/2017 - 06/2011
3	Small Interfering RNA (siRNA)IBA 01/2011 - 08/2004
2	CaspasesIBA 04/2024 - 11/2022
2	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2023 - 11/2020
2	GTP Phosphohydrolases (GTPases)IBA 01/2023 - 02/2005
2	fasudil (AT 877)IBA 01/2020 - 04/2008
2	rho-Associated KinasesIBA 01/2018 - 10/2012
2	Actin Depolymerizing Factors (Cofilins)IBA 01/2015 - 06/2007
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2022
1	Actins (F Actin)IBA 10/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 11/2020
1	Alanine (L-Alanine)FDA Link 11/2020
1	Green Fluorescent ProteinsIBA 11/2020
1	Protein Kinases (Protein Kinase)IBA 11/2020
1	Glutamic Acid (Glutamate)FDA Link 11/2020
1	TenascinIBA 10/2020
1	Mifepristone (RU 486)FDA Link 10/2020
1	AT13148IBA 01/2018
1	BDP9066IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 11/2016
1	Drug CombinationsIBA 11/2015
1	AndrogensIBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	matrigelIBA 10/2014
1	4- chloro- 1- (4- piperidyl)- N- (5- (2- pyridyl)- 1H- pyrazol- 4- yl)pyrazole- 3- carboxamideIBA 10/2014
1	Extracellular Matrix ProteinsIBA 09/2013
1	Amino Acids FDA Link 01/2013
1	Sirolimus (Rapamycin)FDA Link 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2012
1	Tyrosine Kinase InhibitorsIBA 10/2012
1	ChemokinesIBA 09/2012
1	Chemokine ReceptorsIBA 09/2012
1	Transcription Factors (Transcription Factor)IBA 09/2011
1	CarcinogensIBA 06/2011
1	Guanosine Triphosphate (GTP)IBA 02/2011
1	Formaldehyde (Formol)FDA Link 02/2011
1	ParaffinIBA 02/2011
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2011
1	Rho Guanine Nucleotide Exchange FactorsIBA 09/2009
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2006
1	Estrogen ReceptorsIBA 12/2004
1	Hormones (Hormone)IBA 12/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2004
1	Uridine Triphosphate (UTP)IBA 07/2003
1	Adenosine Triphosphate (ATP)IBA 07/2003
1	NucleotidesIBA 07/2003

Therapy/Procedure

12	Therapeutics 11/2022 - 02/2005
1	Drug Therapy (Chemotherapy) 01/2020